These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24360322)

  • 1. Bilateral ovarian metastasis of non-small cell lung cancer with ALK rearrangement.
    Fujiwara A; Higashiyama M; Kanou T; Tokunaga T; Okami J; Kodama K; Nishino K; Tomita Y; Okamoto I
    Lung Cancer; 2014 Feb; 83(2):302-4. PubMed ID: 24360322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization.
    Paik JH; Choe G; Kim H; Choe JY; Lee HJ; Lee CT; Lee JS; Jheon S; Chung JH
    J Thorac Oncol; 2011 Mar; 6(3):466-72. PubMed ID: 21258247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients.
    Park HS; Lee JK; Kim DW; Kulig K; Kim TM; Lee SH; Jeon YK; Chung DH; Heo DS
    Lung Cancer; 2012 Aug; 77(2):288-92. PubMed ID: 22465695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer (NSCLC): results of a multi-centre ALK-testing.
    V Laffert M; Warth A; Penzel R; Schirmacher P; Jonigk D; Kreipe H; Schildhaus HU; Merkelbach-Bruse S; Büttner R; Reu S; Kerler R; Jung A; Kirchner T; Wölfel C; Petersen I; Rodriguez R; Jochum W; Bartsch H; Fisseler-Eckhoff A; Berg E; Lenze D; Dietel M; Hummel M
    Lung Cancer; 2013 Aug; 81(2):200-6. PubMed ID: 23669200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer.
    Pailler E; Adam J; Barthélémy A; Oulhen M; Auger N; Valent A; Borget I; Planchard D; Taylor M; André F; Soria JC; Vielh P; Besse B; Farace F
    J Clin Oncol; 2013 Jun; 31(18):2273-81. PubMed ID: 23669222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordance between anaplastic lymphoma kinase status in primary non-small-cell lung cancers and their corresponding metastases.
    Kim H; Xu X; Yoo SB; Sun PL; Jin Y; Paik JH; Choe G; Jheon S; Lee CT; Chung JH
    Histopathology; 2013 Jan; 62(2):305-14. PubMed ID: 23020707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of stained cytologic direct smears for ALK gene rearrangement analysis of lung adenocarcinoma.
    Betz BL; Dixon CA; Weigelin HC; Knoepp SM; Roh MH
    Cancer Cytopathol; 2013 Sep; 121(9):489-99. PubMed ID: 23536384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive histologic analysis of ALK-rearranged lung carcinomas.
    Yoshida A; Tsuta K; Nakamura H; Kohno T; Takahashi F; Asamura H; Sekine I; Fukayama M; Shibata T; Furuta K; Tsuda H
    Am J Surg Pathol; 2011 Aug; 35(8):1226-34. PubMed ID: 21753699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and Cost Implications of Universal Versus Locally Advanced-Stage and Advanced-Stage-Only Molecular Testing for Epidermal Growth Factor Receptor Mutations and Anaplastic Lymphoma Kinase Rearrangements in Non-Small Cell Lung Carcinoma: A Tertiary Academic Institution Experience.
    Sauter JL; Butnor KJ
    Arch Pathol Lab Med; 2016 Apr; 140(4):358-61. PubMed ID: 27028394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concordance of anaplastic lymphoma kinase (ALK) gene rearrangements between circulating tumor cells and tumor in non-small cell lung cancer.
    Tan CL; Lim TH; Lim TKh; Tan DS; Chua YW; Ang MK; Pang B; Lim CT; Takano A; Lim AS; Leong MC; Lim WT
    Oncotarget; 2016 Apr; 7(17):23251-62. PubMed ID: 26993609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomorphology of non-small cell lung carcinoma with anaplastic lymphoma kinase gene rearrangement.
    Toll AD; Maleki Z
    Diagn Cytopathol; 2015 Jan; 43(1):8-15. PubMed ID: 24723496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of IHC and FISH for ALK gene rearrangement in non-small cell lung carcinoma: IHC score algorithm for FISH.
    Yi ES; Boland JM; Maleszewski JJ; Roden AC; Oliveira AM; Aubry MC; Erickson-Johnson MR; Caron BL; Li Y; Tang H; Stoddard S; Wampfler J; Kulig K; Yang P
    J Thorac Oncol; 2011 Mar; 6(3):459-65. PubMed ID: 21278610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ovarian metastasis and lung adenocarcinoma: a case report].
    Castadot P; Magné N; Berghmans T; Drowart A; Baeyens L; Smets D; Van Houtte P
    Cancer Radiother; 2005 May; 9(3):183-6. PubMed ID: 16023045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian metastasis from lung adenocarcinoma with ALK-positive rearrangement detected by next generation sequencing: A case report and literatures review.
    Jing X; Li F; Meng X; Liu Z; Yu J; Liu B
    Cancer Biol Ther; 2017 May; 18(5):279-284. PubMed ID: 28362192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment and detection of ALK-rearranged NSCLC.
    Peters S; Taron M; Bubendorf L; Blackhall F; Stahel R
    Lung Cancer; 2013 Aug; 81(2):145-54. PubMed ID: 23769207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALK rearrangement: a high-frequency alteration in ovarian metastasis from lung adenocarcinoma.
    Bi R; Bai Q; Zhu X; Tu X; Cai X; Jiang W; Xu X; Tang S; Ge H; Chang B; Cheng Y; Gan H; Zhou X; Yang W
    Diagn Pathol; 2019 Aug; 14(1):96. PubMed ID: 31455365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas.
    Boland JM; Erdogan S; Vasmatzis G; Yang P; Tillmans LS; Johnson MR; Wang X; Peterson LM; Halling KC; Oliveira AM; Aubry MC; Yi ES
    Hum Pathol; 2009 Aug; 40(8):1152-8. PubMed ID: 19386350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALK status testing in non-small cell lung carcinoma: correlation between ultrasensitive IHC and FISH.
    Minca EC; Portier BP; Wang Z; Lanigan C; Farver CF; Feng Y; Ma PC; Arrossi VA; Pennell NA; Tubbs RR
    J Mol Diagn; 2013 May; 15(3):341-6. PubMed ID: 23499337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A year of anaplastic large cell kinase testing for lung carcinoma: pathological and technical perspectives.
    Desai SS; Shah AS; Prabhash K; Jambhekar NA
    Indian J Cancer; 2013; 50(2):80-6. PubMed ID: 23979196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of ALK rearrangement in non-small cell lung cancer: using enhancing immunohistochemical way and fluorescence in situ hybridization].
    Meng H; Gao X; Zhang L; Liu F; Li W
    Zhongguo Fei Ai Za Zhi; 2015 Feb; 18(2):75-9. PubMed ID: 25676399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.